Trials / Sponsors / Immuneering Corporation
Immuneering Corporation
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors Advanced Solid Tumor (Phase 1), Pancreas Adenocarcinoma, Non-small Cell Lung Cancer | Phase 1 / Phase 2 | 2024-02-27 |
| Active Not Recruiting | A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors Advanced Solid Tumor, Pancreatic Adenocarcinoma, Malignant Melanoma (Cutaneous) | Phase 1 / Phase 2 | 2022-10-31 |